Click to Collapse
Desitext Patient Card
COMPANY PROFILE

DESITIN ARZNEIMITTEL GmbH was founded in Berlin in 1919. We developed and successfully introduced the still frequently used Desitin® ointment as our first product. In 1945, Desitin relocated to Hamburg, where the development and sales of medication for illnesses of the central nervous system (CNS) began. The company became a specialist supplier and competent partner […]

Click to Expand
TERRITORIES

Desitin concentrates its marketing efforts on the European continent. In a number of countries (key countries mainly in the UK, Scandinavia and Eastern Europe as well as in Switzerland) Desitin is present with own sales forces, whereas in other countries licencees and partners distribute Desitin’s products.  

Click to Expand
PROMOTED PRODUCTS

Desitin is focused on pharmaceuticals for the treatment of epilepsy. It is the only manufacturer that offers the almost entire spectrum of products recommended by the WHO for the treatment of epilepsy. It should be noted that not all products are available in all countries. Desitin not only offers a wide range of different therapeutics, […]

Click to Expand
PRODUCT AVAILABILITY BY COUNTRIES

Three active ingredients play a major role in Desitin‘s own developments for epilepsy: Valproic acid, which is the first-line therapy for generalized seizures, Carbamazepine, which is of the same relevance for focal seizures, and Oxcarbazepine the more modern alternative to Carbamazepine.

Click to Expand
CORPORATE MILESTONES

Pharmaceutical innovations developed by Desitin as well as the launch of new chemical entities licenced from partners represent corporate milestones throughout Desitin’s history. None of the products shown are available in the UK at this time from Desitin.

Click to Expand
STRONG REPUTATION

Desitin’s straightforward approach together with the quality of its products from own development and licensors consequently lead to its high reputation within its main target group – neurologists – as shown in the results of the survey performed in Germany in 2013. Desitin is starting to build a reputation in the UK.

Click to Expand
INNOVATIONS

Desitin Pharmaceuticals GmbH – galenic innovation for over 40 years 2011 Levetiracetam Desitin The first levetiracetam minitablets worldwide (approved administration form: film-coated granules in sachets) 2010  Sumavel® DosePro® The first ready-to-use, needle free injector for sumatriptan in Europe* 2009 Topiramat Desitin quadro The first quartered topiramate tablet worldwide 2008 Apydan extent The first modified release formulation […]

Click to Expand
SUPPLY CHAIN / PRODUCTION

Pharmaceuticals are developed, manufactured, procured, and tested at Desitin’s Hamburg site under modern conditions and then shipped to our customers worldwide. The comprehensive laws, regulations, and standards conforming to AMG, AMWHV, cGXP, etc. are mapped in a modern process-oriented and flexible organisation. Falsified Medicines Directive (Directive 2016/62/EU) Desitin is compliant with Directive 2016/62/EU. All products […]

Click to Expand
RESEARCH & DEVELOPMENT

Relevant information about our clinical development activities is provided below. At Desitin, we are proud of the fact that for decades we have consistently produced global innovations that have considerably improved and simplified drug treatment for doctors and patients, and have already become standard treatments. These innovations, which were and are always developed in close […]

Click to Expand
OUR HERITAGE

Medium-sized, specialized pharmaceutical company Founded nearly 100 years ago
 in Berlin Independent, family-owned, profitable company, based in Hamburg About 300 employees in development, production, sales, medicine, marketing and administration Established as a specialist in the
 field of epilepsy Addition of further CNS indications Fully integrated pharmaceutical company Incorporating sales & marketing, commercial, medical affairs and […]

Click to Expand
DESITIN PHARMA DISCLOSURE SUMMARY

Desitin Pharma Ltd disclosure of payments to Health Care Professionals (HCPs), Donations and Grants Date of Preparation March 2020

Click to Expand
WHAT IS EPILEPSY?

Epilepsies are a group of entirely diverse disorders. What is common to all of them is that seizures occur from time to time, usually without any warning sign. Epileptic seizures are caused by functional disturbances of the brain. Their clinical manifestation is dependent to a great extent on which area of the brain is malfunctioning. […]

Click to Expand
DEFINITION

A generally valid definition and one that is applicable to all epileptic seizure forms could be the following: Epileptic seizures are relatively brief, sudden changes in consciousness, reasoning, behaviour, memory, senses, or sensation, or the tensing of the musculature due to a temporary functional disturbance of the nerve cells in the brain in the form […]

Click to Expand
EPILEPTIC SEIZURES

Epileptic seizures are disorders of the brain caused by an increased number of brief electrical discharges of nerve cells. There are more than thirty forms of epileptic seizures and even more forms of epilepsy because these can also involve combinations of several different types of seizures. Every person affected by epilepsy generally has only one […]

Click to Expand
SEIZURE DESCRIPTION

Epileptic seizures can have very diverse manifestations. They can occur without screaming or loss of consciousness, without stiffening, tongue biting, and collapsing, without turning blue or having convulsions. They can be so harmless that neither the person affected realises it nor the non-expert notices anything when they directly observe a seizure. The only sign of […]

Click to Expand
EFFECT ON NERVE CELLS

Every nerve cell and every cluster of nerve cells in the brain can become ‘epileptic’, leading to disruption or discontinuation of their normal activity. If the cells are responsible for the sense of smell an olfactory disturbance results. If they are normally responsible for sight, the perception of light flashes or other light stimuli can […]

Click to Expand
CAUSES

The expression “epileptic attacks” is a collective designation behind which there can be very diverse disorders. However, for many people the cause of seizures is still elusive even with the methods available today. Not every epileptic-like attack is synonymous with epilepsy. For example, almost every person will experience an epileptic seizure under the following conditions: […]

Click to Expand
PREJUDICES

Epilepsy still belongs to the health disorders that are met with a variety of false perceptions and prejudices by the public even though specialized knowledge particularly in this area has increased tremendously in the past decades. The famous Greek doctor Hippocrates (460 – 375 BC) recognized that epilepsy was due to a disturbance in the […]

Click to Expand
SUPPORTING PATIENT ORGANISATIONS

At Desitin Pharma Ltd we recognise and support the important work of patient organisations to improve the quality of life for epilepsy patients in the UK. We also regularly work with healthcare professionals on a range of issues relevant to our products and the epilepsy disease area. The advice, insight and knowledge we can gain […]

Click to Expand
ART AT DESITIN

Click to see Art at Desitin It is a little known fact that a large number of world-famous artists suffer from neurological or psychiatric illnesses; Desitin has set itself the task of alleviating the symptoms of these ailments. An illness, especially if it is chronic, always represents an irritation in a person’s life and can significantly impair their quality of life. […]

Click to Expand
SEIZURE DIARY

Download a diary from the Epilepsy Society website Keeping a regular record of your seizures helps to monitor your triggers and helps medical staff review your treatment. Patient support organisations, such as Epilepsy Society have paper, PDF and an app version of a diary you can use. What is a seizure diary for? Keeping a […]

Click to Expand
DESITREND® 250mg
COATED GRANULES IN SACHET

Please click here for SMPC and patient leaflet information

Click to Expand
DESITREND® 500mg
COATED GRANULES IN SACHET

Please click here for SMPC and patient leaflet information

Click to Expand
DESITREND® 1000mg
COATED GRANULES IN SACHET

Please click here for SMPC and patient leaflet information

Click to Expand
EPISENTA®▼ 150mg
PROLONGED RELEASE CAPSULES

Please click here for SMPC, patient leaflet and risk materials

Click to Expand
EPISENTA®▼ 300mg
PROLONGED RELEASE CAPSULES

Please click here for SMPC, patient leaflet and risk materials

Click to Expand
EPISENTA®▼ 500mg
PROLONGED RELEASE GRANULES

Please click here for SMPC, patient leaflet and risk materials

Click to Expand
EPISENTA®▼ 1000mg
PROLONGED RELEASE GRANULES

Please click here for SMPC, patient leaflet and risk materials

Click to Expand
DIAZEPAM 5mg
RECTAL SOLUTION

Please click here for SMPC and patient leaflet information

Click to Expand
DIAZEPAM 10mg
RECTAL SOLUTION

Please click here for SMPC and patient leaflet information

Click to Expand
DESITREND®
100mg CONCENTRATE FOR SOLUTION FOR INFUSION

Please click here for SMPC and patient leaflet information

Click to Expand
AVAILABILITY OF PRODUCTS INTERNATIONALLY

We recommend that if you plan to go on a vacation or plan to work abroad you should always discuss with your Doctor to ensure you have adequate supply of your medicines to last the duration of your trip. However if you run out of medicine you can check out the availability of Desitin Medicines […]

Click to Expand
Are you visiting this website as a member of the public or as a medical professional?
Member of the public
Medical Professional